Use the Search Fields to Find Information
Page 12 of 339
Two-center experience of cannabidiol use in adults with Dravet syndrome
Abstract We describe real-world experience with cannabidiol (CBD) in adults with Dravet Syndrome (DS) via GW Pharma early access programme at two UK neurology centres.
April 25, 2024
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
BACKGROUND The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. We studied cannabidiol for
September 19, 2019
Trends over time in adult cannabis use: A review of recent findings
Please use this link to access this publication. Abstract In the United States, policies regarding the medical and nonmedical use of cannabis are changing rapidly.
May 8, 2025
Trends in youth cannabis use across cannabis legalization: Data from the COMPASS prospective cohort study
Abstract Canada legalized recreational cannabis use for adults on October 17, 2018 with decision-makers emphasising the need to reduce cannabis use among youth. We sought
May 16, 2025
Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022
Please use this link to access this publication. Abstract Background: As medical cannabis availability increases, up-to-date trends in medical cannabis licensure can inform clinical policy
December 2, 2024
Trends in cannabis use intention around the period of cannabis legalisation in Australia: An age-period-cohort model
Abstract Introduction: This study examines age, time period and birth cohort trends in cannabis use intention and weekly use in Australia over a period in which
October 3, 2024
Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017
Abstract Objective Forthcoming legislative changes will legalize and make cannabis widely available in Canada. We conducted an analysis of Ontario’s birth registry to determine recent
December 17, 2024
Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
Abstract Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological,
May 30, 2024
Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
Hypercholesterolemia is one of the most important risk factors for erectile dysfunction, mostly due to the impairment of oxidative stress and endothelial function in the
September 19, 2019
Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression
Abstract Endo-, phyto- and synthetic cannabinoids have been proposed as promising anti-cancer agents able to impair cancer cells’ behavior without affecting their non-transformed counterparts. However,
October 3, 2025
Page 12 of 339